Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead.
about
Transcatheter embolization therapy in liver cancer: an update of clinical evidencesComparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beadsComparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer.Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol.Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.New progress of non-surgical treatments for hepatocellular carcinoma.MRI Findings and Prediction of Time to Progression of Patients with Hepatocellular Carcinoma Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization.Drug-eluting bead therapy in primary and metastatic disease of the liver.Treatment options for unresectable neuroendocrine liver metastases.Surgical and Locoregional Therapy of HCC: TACE.Review of the Development of Methods for Characterization of Microspheres for Use in Embolotherapy: Translating Bench to Cathlab.Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre.Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo modelsTransarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.Lokalablative Therapien zur Behandlung des hepatozellulären KarzinomsNew Insights into the Mechanisms of the Interactions Between Doxorubicin and the Ion-Exchange Hydrogel DC Bead™ for Use in Transarterial Chemoembolization (TACE)
P2860
Q27003849-C5A2161E-A497-49FC-8B97-05446DA4DDD9Q28542950-E923A034-2D03-4983-88F7-02037A41CD7FQ34110928-7E352E01-611D-46D7-892F-5C5D6CB9D077Q34324995-10D31C9D-EDA5-4928-919A-C11180425F01Q34623728-58ABDE1E-83C0-4CBC-828B-4293F9E39960Q34647076-31DA48F3-9BF7-419A-82EB-75C3FDC0EB9BQ35778627-E28864DB-6B37-408C-ACE6-FBD742916960Q37449338-0EBB957B-4D7B-4FEB-BAD5-56C851AD3250Q38014498-F97C4C2F-0FB3-490C-A80B-340B9BBA81C3Q38671236-1ED0CE85-4DF8-4704-A766-5DD965A677AFQ39144395-93173653-1B03-4492-9284-710342944E1FQ40020398-A68077AA-909B-40FA-B687-623432DD3104Q41951864-041C88D4-DC1D-4D5B-B732-478ADD4CA33FQ42379112-B3E1314E-1597-48FE-9F62-879DAECDE55AQ51063349-DE7C504C-63E0-47BA-A19E-E5BDDE3DEBB3Q57079476-473B9C63-0672-46CC-A0DB-932D7B949373Q57371751-AFAC08AA-A24C-4642-87C7-7D5D419336AF
P2860
Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug-eluting particles in the ...... th doxorubicin-loaded DC Bead.
@en
Drug-eluting particles in the ...... th doxorubicin-loaded DC Bead.
@nl
type
label
Drug-eluting particles in the ...... th doxorubicin-loaded DC Bead.
@en
Drug-eluting particles in the ...... th doxorubicin-loaded DC Bead.
@nl
prefLabel
Drug-eluting particles in the ...... th doxorubicin-loaded DC Bead.
@en
Drug-eluting particles in the ...... th doxorubicin-loaded DC Bead.
@nl
P2860
P1476
Drug-eluting particles in the ...... th doxorubicin-loaded DC Bead.
@en
P2093
Katerina Malagari
P2860
P304
P356
10.1586/14737140.8.10.1643
P577
2008-10-01T00:00:00Z